What’s Patentable? Eduardo Quinones, Ph.D., Esq. Amy A. Dobbelaere, Ph.D.

Slides:



Advertisements
Similar presentations
Intellectual Property (ref: Engineering by Design by Gerard Voland)
Advertisements

Utility and Written Description Steve Kunin Deputy Commissioner for Patent Examination Policy Esther Kepplinger Deputy Commissioner for Patent Operations.
Industrial Property the Patent system
Diagnostics: Patent Eligibility and the Industry Perspective
MSE-415: B. Hawrylo Chapter 14 - Patents There are 4 types of intellectual property that are relevant to product design and development
What is Happening to Patent Eligibility and What Can We Do About It? June 24, 2014 Bruce D. Sunstein Denise M. Kettelberger, Ph.D. Sunstein Kann Murphy.
INTRODUCTION TO PATENT RIGHTS The Business of Intellectual Property
1 Bioinformatics Practice Considerations October 20, 2011 Ling Zhong, Ph.D.
PATENTABLE SUBJECTS IN THE INTERNET OF THINGS ALICIA SHAH.
AIPLA Biotechnology Committee Webinar: Mayo v. Prometheus: Did the Bell Toll for Personalized Medicine Patents? Prof. Joshua D. Sarnoff DePaul U. College.
“REACH-THROUGH CLAIMS”
Patents Copyright © Jeffrey Pittman. Pittman - Cyberlaw & E- Commerce 2 Legal Framework of Patents The U.S. Constitution, Article 1, Section 8:
1 TC 1600 Subject Matter Eligibility Under 35 USC § 101 Andrew Wang SPE 1631 (571)
Patent Overview by Jeff Woller. Why have Patents? Patents make some people rich – but, does that seem like something the government should protect? Do.
Applications for Intellectual Property International IP Protection IP Enforcement Protecting Software JEFFREY L. SNOW, PARTNER NATIONAL SBIR/STTR CONFERENCE.
Examiner Guidelines After Alice Corp. August 21, 2014 How Much “More” is “Significantly More”?
Intellectual Property Overview for the Academic Researcher AMSTER ROTHSTEIN & EBENSTEIN LLP December 9, 2008 Kenneth George.
Lauren MacLanahan Office of Technology Licensing GTRC.
Patentable Subject Matter and Design Patents,Trademarks, and Copyrights David L. Hecht, J.D., M.B.A, B.S.E.E.
© 2010 Hodgson Russ LLP IEEE Southern Area Entrepreneur’s Day Overview Of The Patent Process R. Kent Roberts Hodgson Russ LLP (716)
Rodolphe Bauer, Frédéric Dedek, Gareth Jenkins, Cristina Margarido
Utility Requirement in Japan Makoto Ono, Ph.D. Anderson, Mori & Tomotsune Website:
35 USC 101 Update Business Methods Partnership Meeting, Spring 2008 by Robert Weinhardt Business Practice Specialist, Technology Center 3600
Biotechnology/Chemical/Pharmaceutical Customer Partnership: Recent Examiner Training and Developments Under 35 USC § 101 Drew Hirshfeld Deputy Commissioner.
An invention is a unique or novel device, method, composition or process. It may be an improvement upon a machine or product, or a new process for creating.
© Kolisch Hartwell 2014 All Rights Reserved, Page 1 Oregon Best Fest September 2014 Peter D. Sabido Intellectual Property Attorney Kolisch Hartwell, P.C.
Biotech Inventions in Latin America Argentina Ignacio Sánchez Echagüe Marval, O’Farrell & Mairal.
2/2/09 - L14 PatentsCopyright Joanne DeGroat, ECE, OSU1 Patents.
Impact of Myriad Decisions on Patent Eligibility of Biotechnology Inventions in Australia and the US.
Post-Bilski Patent Prosecution IP Osgoode March 13, 2009 Bob Nakano McCarthy Tétrault LLP.
Introduction to Patents Anatomy of a Patent & Procedures for Getting a Patent Margaret Hartnett Commercialisation & IP Manager University.
Hamre, Schumann, Mueller & Larson, P.C U.S. Patent Claims By James A. Larson.
1 INTELECTUAL PROPERTY PATENTS. 2 A patent for an invention grants property rights of that invention to the inventor. It is issued by the Patent and Trademark.
Intellectual Property: Patent Eligible Subject Matter Prof. Peng
© 2011 Dannemann Siemsen. Todos os direitos reservados. Biotech IP issues in Brazil Gustavo Morais May 2011 Gustavo Morais May 2011.
6.1 Chapter 6 Patents © 2003 by West Legal Studies in Business/A Division of Thomson Learning.
1 Demystifying the Examination of Stem Cell-Related Inventions Remy Yucel, Ph.D. Supervisory Patent Examiner Technology Center 1600 United States Patent.
Data Governance Patents, Security and Privacy Duke University, November 9, 2015 Ryan Vinelli.
Patent Searching Basics Patrick M. Torre, Ph.D. November 18, 2015.
1. 35 USC § 101: Statutory Requirements and Four Categories of Invention August 2015 Office of Patent Legal Administration United States Patent and Trademark.
Examination Practice in Applications Presenting “Reach-Through Claims” George Elliott Practice Specialist Technology Center 1600
Mayo v. Prometheus Labs – The Backdrop June 12, 2012 © 2012, all rights reserved.
Patentable Subject Matter Donald M. Cameron. 2 Patents: The Bargain Public: gets use of invention after patent expires Inventor/Owner: gets limited monopoly.
© 2008 International Intellectual Property June 16, 2009 Class 2 Introduction to Patents.
Fundamentals of Intellectual Property
Patents and the Patenting Process Patents and the Inventor’s role in the Patenting Process.
Introduction The Patentability of Human Genes Is patenting human genes moral? Should it be legal? Should there be international intervention?
Nov. 26, 2006 Kuzuwa & Partners1 Care required to draft pharma patents and prosecution of pharma patents Ahmedabad, November 26, 2006 Kiyoshi Kuzuwa Patent.
BLW 360 – January 27, 2015 Jonathan LA Phillips
Intellectual Property & Contemporary Issues of Biotechnology Law
Patents 101 March 28, 2006 And now, for something new, useful and not obvious.
The Challenge of Biotech Patent Eligibility in the United States:
Alexandria, Virginia July 21, 2014
Ahmedabad, November 26, 2006 Kiyoshi Kuzuwa Patent Attorney
Preparing a Patent Application
PATENTS IT.CAN Annual Meeting
Of Counsel Polsinelli, LLP
ChIPs Global Summit, September 15, 2016
Nuts and Bolts of Patent Law
Comparing subject matter eligibility in us and eu
Patentable Subject Matter
Preparing a Patent Application
GENERAL INTRODUCTION THE PATENT SYSTEM.
What are the types of intellectual property ?
A tutorial and update on patentable subject matter
What are the types of intellectual property?
Examination Practice in Applications Presenting “Reach-Through Claims”
Patentable Subject Matter in Korea
Jonathan D’Silva MMI Intellectual Property 900 State Street, Suite 301
Presentation transcript:

What’s Patentable? Eduardo Quinones, Ph.D., Esq. Amy A. Dobbelaere, Ph.D.

A patent is a property right – Prevents others from making, using or selling your invention without your permission – Exclusionary Right – One Patent – One Jurisdiction WHAT IS A PATENT?

DesignPlantUtility For today, we will focus on Utility Patents TYPES OF PATENTS

In the United States – Provisional Applications – Non-provisional Applications Around the world – Patent Cooperation Treaty (PCT) Application and National Stage Filings – Direct National Filings Timing – File first application before your first public disclosure* – File subsequent applications around the world within a year or country-specific deadlines for PCT. TYPES OF UTILITY APPLICATIONS

35 U.S.C. 101: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefore, subject to the conditions and requirements of this title. Inventions must be new, useful, and non-obvious Around the world: New, involve an inventive step (~non-obvious), and have industrial applicability (~useful) SO WHAT CAN I PATENT?

“Engineering” – Mechanical, Electrical, Chemical, Software or combinations thereof – Usually protecting: Devices/systems or components thereof Methods of operation, use, or manufacture Biotechnology Inventions – Molecular biology, Gene therapy, Virology, Genetics, Immunology, Stem cell technology, etc. – Usually protecting: Compositions, methods of making & using Diagnostic kits/methods Transgenic organisms TYPES OF INVENTIONS

Prepare invention disclosure or other materials to share with patent professional Patent professional prepares application* – Specification/Description – Drawings – Claims Application is filed Examination Allowance Patent is Issued! Total time – Several years PATENT APPLICATION PROCESS

In the U.S., application will generally be examined to ensure compliance with: – 35 U.S.C. 101 – Something that can be patented? – 35 U.S.C. 102 – Is it new in view of the prior art? – 35 U.S.C. 103 – Is it non-obvious in view of the prior art? – 35 U.S.C. 112 – Does the application have (1) An adequate description of the invention? (2) Enough details to practice the invention? PATENTABILITY REQUIREMENTS IN THE U.S.

Most Engineering-type inventions – Typically straightforward to describe and claim in application – Examination typically limited to claim form in view of prior art However, certain types of inventions require additional considerations: – Biotech inventions – Software inventions PATENTABILITY REQUIREMENTS IN THE U.S. (Cont’d)

CONSIDERATIONS FOR BIOTECH PATENT APPLICATIONS

Description and Figures ―As detailed a description as possible, including examples of several embodiments for a given invention ―In the ‘Examples’ section, inclusion of all relevant data, in vivo data always preferred ―Data figures Claims ―Composition consisting of or comprising… ―Method of treating disease X in a subject comprising administering the composition… ―Method of making a composition comprising…, the method comprising the steps of: a, b and c ―Method for analyzing X in a sample… ―A kit for analyzing X or treating disease X… TYPICAL BIOTECH PATENT APPLICATION/PATENT

In EPO, plant & animal varieties & biological processes for production thereof, methods for treatment of the human or animal body by surgery or therapy & diagnostic methods practiced on the human or animal body not patentable In EPO, patenting of stem cells is controversial – EPO does not process stem cell applications while the UK & DE patent offices follow a less stringent approach In JPO, methods to treat humans, specifically through surgery, general treatment, or diagnosis are not patentable. In Canada, methods of medical treatment & higher life forms are not patentable BIOTECH PATENTS AROUND THE WORLD

U.S. patent rules provide applicants with relatively flexible rules for amending claims during patent prosecution. EP in particular has more stringent claim support requirements – EP examiners typically don’t allow cobbling together an amended claim out of different embodiments. In EP, providing numerous embodiments of a given invention is a necessity, & describing how to combine various features of the disclosed embodiments may also be. China and Australia moving in EP’s direction JPO strictly requires that patent applications claiming medical uses (pharmaceutical inventions) should disclose "pharmacological test data or the equivalent" in the specification. BIOTECH PATENTS AROUND THE WORLD (cont.)

The USPTO considers non-naturally occurring, non- human multicellular organisms, including animals, to be patentable subject matter ―Microorganisms (bacteria, yeast, fungi) ―Embryonic stem cells ―Plants ―Animals ―Cellular / Biological Processes ―Genes and Nucleotide Sequences ―Gene Products (proteins) ―Biologically Derived Chemicals / Pharmaceuticals ―Diagnostic reagents ―Methods of treatment ―Medical Devices BIOTECH PATENTS IN THE U.S.

Recent Case Law/Issues ― Mayo Collaborative Services v. Prometheus Laboratories, Inc. ―2013 – Ass’n for Molecular Pathology v. Myriad Genetics ―2014 – AbbVie v. Janssen Biotech and Centocor Biologics ―Higher enablement (35 U.S.C. 112) standard compared to other fields ―Experimental data very important in many cases, in vivo more compelling than in vitro, e.g., claims for ‘method of preventing…’ & vaccines require substantial in vivo data for support BIOTECH PATENTS IN THE U.S. (cont.)

CONSIDERATIONS FOR SOFTWARE PATENT APPLICATIONS

Generally two main aspects for any type of software: – Algorithms, methods, and other general concepts that describe, at a high level, how the software operates; and – Actual computer code for implementing these concepts. Patents - Target the high level concepts Other types of protection are typically used for computer code (e.g., Copyright) PATENTING SOFTWARE

Description and Drawings: – Operating Environment – Particular/specialized components – Flow charts for each process – General Computer description/schematic Claims – Method – Computer-Product Claims – System Claims TYPICAL SOFTWARE-BASED PATENT

EXAMPLE OF SOFTWARE PATENT

Outside the U.S., obtaining software-based patents can be difficult: – Excluded by law; or – Excluded by problem/solution examination Problem/Solution Examination requires determining: – Problem being solved  A technical one?; – Solution being claimed: Would it be obvious to adapt the closest prior art to provide the solution? Does solution provides a technical effect or advantage over the closest prior art.* Thus, completely new software methods may be unpatentable overseas unless one can demonstrate a tangible, technical advantage of the method or system implementing the method. SOFTWARE PATENTS AROUND THE WORLD 20

Patents can be obtained for software-based inventions in the U.S. – Software per se is not patentable in the U.S. – However, methods implementing software-based inventions or articles of manufacture implementing such methods may be patentable To a major extent, examination is straight forward However, recent developments have imposed additional requirements SOFTWARE PATENTS IN THE U.S.

35 U.S.C. 101: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Pre-2010 – Machine or Transformation (MT) Test Bilski V. Kappos – MT test not sole measure of patentability Alice v. CLS - Claims directed to an abstract idea or a generic computer implementation of an abstract idea are ineligible for patent protection MAIN ISSUE - IS A SOFTWARE-BASED INVENTION ELIGIBLE FOR PATENT PROTECTION?

USPTO Examination (still developing) (1) Is the claim directed to an abstract idea? (2) If so, are there other claim features that show a patent-eligible application of the abstract idea, e.g., more than a mere instruction to apply the abstract idea? What does this mean? – Does the claim recite a way to use the abstract idea solve a technical problem?; or – Does the abstract idea provide some type of technical advantage? In sum  a problem/solution or technical step type approach to determine patent eligibility – No clear guidance yet, but consistent with Post-Alice decisions SOFTWARE-BASED PATENTS AFTER ALICE V. CLS?

Invention disclosures – Don’t limit description to just the software and how it works – Describe, in detail, technical problems solved by the software or a system implementing the software – Describe, in detail, any technical advantages of using the software e.g., improved computational speed, reduced memory demands, not just a business advantage. Working with patent professionals – Read draft applications in their entirety (you are supposed to do so anyways!) and make sure technical advantages and/or technical problems solved by the software are discussed as fully as possible. SO WHAT DO YOU NEED TO DO?

Eduardo Quinones, Ph.D., Esq. (561) Amy A. Dobbelaere, Ph.D. (561) Novak Druce Connolly Bove + Quigg LLP Cityplace Tower, 15 th Floor 525 Okeechobee Blvd West Palm Beach, FL CONTACT INFORMATION

Questions?